131I,~(131)I
1)~(131)I131I
1.In this paper,method and principle of calibrating γdetecting efficiency of~(131)I charcoal cartridge sampler based on~(133)Ba standard source instead of~(131)I standard source are introduced.介绍了一种基于133B a标准源代替131I标准源刻度N aI(T l)闪烁体探测器对131I取样滤盒的γ总探测效率的原理和方法。
2.To investigate the relationship between prognosis of Graves disease(GD) treated with ~(131)I and IL-2,IL-10 and TNF-α,the levels of IL-2,IL-10,TNF-α,T3,T4,FT3,FT4 and s-TSH in serum of 158 patients with GD were measured before first ~(131)I treatment and after five months.探讨Graves病131I治疗后的转归与细胞因子IL-2、IL-10、TNF-α之间的关系。
3.Objective To evaluate the role of amiodarone combined with ~(131)I in Graves disease complicated with atrial fibrillation.目的研究胺碘酮联合131I治疗伴发房颤的G raves病的疗效。
Iodine-131131I
1.Methods Iodine-131 labeled anti-CD20McAb by iodogen method.目的探讨131I-anti-CD20McAb经瘤内注射后在荷人Burkitt’s淋巴瘤细胞系Raji细胞移植瘤裸鼠体内的放射免疫显像。
2.Methods:Iodine-131 labeled anti-CD20 McAb by iodogen method.目的:探讨131I-anti-CD20 McAb经瘤内注射后在荷人Burkitts淋巴瘤细胞系Raji细胞移植瘤裸鼠体内的动态分布。
3)~(131)I-MPPI131I-MPPI
1.The synthesis and biological evaluation of serotonin(5HT_(1A)) imaging agent _4-iodo-N-_1-piperazinyl]ethyl-N-2-pridinyl-benzami-de(~(131)I-MPPI)were reported.为了找到适合123I标记的5-羟色胺(5-HT1A)受体显像剂,合成了4-三正丁基锡-N-[2-[1-(2-甲氧基苯基)]-1-哌嗪基]乙基-N-2-吡啶基-苯甲酰胺(MPPBu3Sn,标记前体),并采用双氧水标记法进行131I标记,得到标记物131I-MPPI,标记率大于90%,放化纯大于99%。
4)~(131)I-IMPY131I-IMPY
1.The synthesis and biodistribution of β-amyloid plaques imaging agent _2-(4′-dimethylaminophenyl)-6-iodoimidazo\ pyridine(~(131)I-IMPY) is reported.为了找到合适的123I标记的脑内β淀粉样蛋白(Aβ)斑块的显像剂,根据文献资料,合成了2-(4′-二甲基氨基苯基)-6-三正丁基锡咪唑并[1,2-α]吡啶(IMPY),并采用双氧水标记法进行了131I标记,得到标记物131I-IMPY,放射化学纯度大于95%。
5)131 I-IBZM131I-IBZM
1.Objective To evaluate the usefulress of SPECT with 131 I-IBZM in imaging of D 2 Dopamine receptors in patients with Parkinson s disease(PD).目的 探讨131I-IBZM脑多巴胺D2 受体SPECT显像在帕金森病中的临床应用价值。
6)131I therapy131I治疗
1.Objective To study the value of TSAb detection for hypothyroidism after in 131I therapy on hyperthyreosis.目的探讨131I治疗甲亢患者后发生甲状腺功能减退症与TSAb、MCA的关系。
2.Objective To determine the relationgship between the serum levels of Tg and TgAb by reviewing the results of patients with differentiated thyroid cancer(DTC) before every 131I therapy.方法:DTC患者141例,首次131I治疗前检查128人次,重复治疗前检查共计120人次,按Tg水平分为5组,比较各组间TgAb阳性率。
3.To investigate dynamic change of serum receptor and antibody of thyrotrophic antibody(TRAb) and its prognosis value after a one-off successful therapy on Graves disease with 131I,257 Graves disease patients were treated with one dose of 131I therapy.分析Graves病131I治疗一次性成功后,患者血清促甲状腺激素受体抗体(TRAb)的动态变化规律及其预后价值。
延伸阅读

iodohippurate sodium [131I]分子式:CAS号:性质:又称邻碘[131I]马尿酸钠。本品由邻碘马尿酸与碘[131I]化钠为原料制得。静注本品后,立即随血流进入肾脏;其中20%由肾小球滤过,80%由肾小管分泌,碘[131I]从血流经肾尿路的全过程。用于肾功能检查、肾显像以及泌尿道通畅情况观察。制剂为注射剂。注意:孕妇、哺乳妇慎用;有过敏反应的可能;铅器存放。副作用有恶心、呕吐、皮肤发红、痒及昏厥的病例报告。